Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary
To assess the impact of COVID-19 restrictions on cystic fibrosis (CF)
pulmonary exacerbations (PEx) we performed a retrospective review of PEx
events at our CF Center and compared the rate of PEx in 2019 vs 2020.
Restrictions on social interaction due to the COVID-19 pandemic were
associated with a lower rate of PEx at our pediatric CF Center,
suggesting that these restrictions also reduced exposure to other
respiratory viral infection in children with CF.